Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.
Saved in:
| Title: | Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. |
|---|---|
| Authors: | Munster, P. N.1 pmunster@medicine.ucsf.edu, Marchion, D.2, Thomas, S.1, Egorin, M.3, Minton, S.2, Springett, G.2, Lee, J.-H.2, Simon, G.2, Chiappori, A.2, Sullivan, D.2, Daud, A.1 |
| Source: | British Journal of Cancer. 10/12/2009, Vol. 101 Issue 7, p1044-1050. 7p. 3 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/sj.bjc.6605293 |
